These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29541420)

  • 1. Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis.
    Xiong Y; Wang T; Wang M; Zhao J; Li X; Zhang Z; Zhou Y; Liu J; Jia L; Han Y
    Oncotarget; 2018 Feb; 9(13):11377-11386. PubMed ID: 29541420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung
    Wang J; Han X; Yuan Y; Gu H; Liao X; Jiang M
    Front Genet; 2022; 13():821675. PubMed ID: 35450214
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
    Song Y; Li H; Jiang Q; Wu L
    Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Guo H; Huang S; Li S; Yu H; Wu S; Zhou X
    Cancer Manag Res; 2018; 10():1763-1779. PubMed ID: 29988744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
    Su G; He Q; Wang J
    Front Physiol; 2018; 9():652. PubMed ID: 29899709
    [No Abstract]   [Full Text] [Related]  

  • 7. Long noncoding RNAs as potential biomarkers and therapeutic targets in gallbladder cancer: a systematic review and meta-analysis.
    Zhong Y; Wu X; Li Q; Ge X; Wang F; Wu P; Deng X; Miao L
    Cancer Cell Int; 2019; 19():169. PubMed ID: 31297033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis.
    Jing W; Li N; Wang Y; Liu X; Liao S; Chai H; Tu J
    Oncotarget; 2017 Jan; 8(3):3957-3968. PubMed ID: 27992369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
    Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
    Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Min SH; Zheng QQ
    Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation.
    Li Z; Huang Y; Zhou R; Li Z; Yan Q
    Medicine (Baltimore); 2023 Jul; 102(29):e34312. PubMed ID: 37478236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Expression of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Cancer.
    Huang X; Zhang Z; Qing X; Zhang W; Zhong B; Deng X; Wang S; Cheng C; Hu H; Shao Z
    J Cancer; 2019; 10(8):1825-1832. PubMed ID: 31205539
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis.
    Xie J; Wu Y; Bian X; Chen D; Gui Q; Huang J
    Int J Clin Exp Pathol; 2018; 11(7):3703-3707. PubMed ID: 31949753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
    Fang C; Wang L; Gong C; Wu W; Yao C; Zhu S
    J Cell Mol Med; 2020 Mar; 24(6):3282-3291. PubMed ID: 32048814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
    Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
    Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
    Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
    Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis.
    Mardani M; Rashedi S; Keykhaei M; Farrokhpour H; Azadnajafabad S; Tavolinejad H; Rezaei N
    Pathol Res Pract; 2022 Jan; 229():153726. PubMed ID: 34942515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.